Edition:
United States

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

2.70USD
21 Sep 2018
Change (% chg)

$-0.06 (-2.17%)
Prev Close
$2.76
Open
$2.76
Day's High
$2.79
Day's Low
$2.63
Volume
24,127
Avg. Vol
34,406
52-wk High
$20.40
52-wk Low
$2.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -1.687
Mar '18 0.00 -2.068
FY 2017 Dec '17 0.00 -3.220
Sep '17 0.00 -2.576
Jun '17 0.00 -2.319
Mar '17 0.00 -2.407
FY 2016 Dec '16 0.00 -3.436
Sep '16 0.00 -4.260
Jun '16 0.00 -4.928
Mar '16 0.00 9.097
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 1 -0.83 -0.83 -0.83 -2.20
Quarter Ending Dec-18 1 -0.87 -0.87 -0.87 -2.30
Year Ending Dec-18 1 -3.59 -3.59 -3.59 -8.70
Year Ending Dec-19 1 -3.03 -3.03 -3.03 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 32.69
P/E High - Last 5 Yrs. -- 42.01 47.23
P/E Low - Last 5 Yrs. -- 23.55 24.79
Beta 0.63 0.90 0.87
Price to Sales (TTM) -- 4.40 6.46
Price to Book (MRQ) 1.02 3.53 3.90
Price to Tangible Book (MRQ) 3.20 5.08 5.96
Price to Cash Flow (TTM) -- 22.16 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.83 1.69
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.56 -5.70
Payout Ratio(TTM) -- 49.41 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.62 8.38
Sales (TTM) vs TTM 1 Yr. Ago -- 4.61 6.69
Sales - 5 Yr. Growth Rate -- 6.93 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago 27.26 18.77 25.56
EPS (TTM) vs TTM 1 Yr. Ago 23.11 -- --
EPS - 5 Yr. Growth Rate -- 6.47 7.60
Capital Spending - 5 Yr. Growth Rate 28.83 7.80 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.19 2.19
Current Ratio (MRQ) 2.19 2.93 2.97
LT Debt to Equity (MRQ) 0.01 8.97 11.24
Total Debt to Equity (MRQ) 0.08 11.26 14.06
Interest Coverage (TTM) -- 41.23 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.11 54.67
Gross Margin - 5 Yr. Avg. -- 53.34 53.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.71 15.88
Operating Margin (TTM) -- 13.28 3.65
Operating Margin - 5 Yr. Avg. -- 14.29 11.00
Pre-Tax Margin (TTM) -- 13.67 3.97
Pre-Tax Margin - 5 Yr. Avg. -- 14.59 11.19
Net Profit Margin (TTM) -- 10.29 0.70
Net Profit Margin - 5 Yr. Avg. -- 10.88 7.52
Effective Tax Rate (TTM) -- 20.47 20.44
Effective Tax Rate - 5 Yr. Avg. -- 23.83 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 820,431,328 714,979,821
Net Income/Employee (TTM) -- 94,873,964 82,568,832
Receivable Turnover (TTM) -- 5.00 5.01
Inventory Turnover (TTM) -- 2.52 3.61
Asset Turnover (TTM) 0.00 0.83 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -142.32 10.03 9.75
Return on Assets - 5 Yr. Avg. -79.65 11.38 10.91
Return on Investment (TTM) -177.43 13.04 12.72
Return on Investment - 5 Yr. Avg. -123.05 14.69 14.03
Return on Equity (TTM) -197.73 14.99 14.85
Return on Equity - 5 Yr. Avg. -139.34 15.90 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 21.47 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.18%
# of Holders: 23
Total Shares Held: 150,399
3 Mo. Net Change: 21,862
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 3
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.